These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 12773479)

  • 1. Binding of the CC-chemokine RANTES to syndecan-1 and syndecan-4 expressed on HeLa cells.
    Slimani H; Charnaux N; Mbemba E; Saffar L; Vassy R; Vita C; Gattegno L
    Glycobiology; 2003 Sep; 13(9):623-34. PubMed ID: 12773479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RANTES (CCL5) induces a CCR5-dependent accelerated shedding of syndecan-1 (CD138) and syndecan-4 from HeLa cells and forms complexes with the shed ectodomains of these proteoglycans as well as with those of CD44.
    Charnaux N; Brule S; Chaigneau T; Saffar L; Sutton A; Hamon M; Prost C; Lievre N; Vita C; Gattegno L
    Glycobiology; 2005 Feb; 15(2):119-30. PubMed ID: 15355933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A syndecan-4/CXCR4 complex expressed on human primary lymphocytes and macrophages and HeLa cell line binds the CXC chemokine stromal cell-derived factor-1 (SDF-1).
    Hamon M; Mbemba E; Charnaux N; Slimani H; Brule S; Saffar L; Vassy R; Prost C; Lievre N; Starzec A; Gattegno L
    Glycobiology; 2004 Apr; 14(4):311-23. PubMed ID: 15033938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of RANTES with syndecan-1 and syndecan-4 expressed by human primary macrophages.
    Slimani H; Charnaux N; Mbemba E; Saffar L; Vassy R; Vita C; Gattegno L
    Biochim Biophys Acta; 2003 Oct; 1617(1-2):80-8. PubMed ID: 14637022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Syndecan-4 is a signaling molecule for stromal cell-derived factor-1 (SDF-1)/ CXCL12.
    Charnaux N; Brule S; Hamon M; Chaigneau T; Saffar L; Prost C; Lievre N; Gattegno L
    FEBS J; 2005 Apr; 272(8):1937-51. PubMed ID: 15819887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The shedding of syndecan-4 and syndecan-1 from HeLa cells and human primary macrophages is accelerated by SDF-1/CXCL12 and mediated by the matrix metalloproteinase-9.
    Brule S; Charnaux N; Sutton A; Ledoux D; Chaigneau T; Saffar L; Gattegno L
    Glycobiology; 2006 Jun; 16(6):488-501. PubMed ID: 16513763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. I-TAC/CXCL11 is a natural antagonist for CCR5.
    Petkovic V; Moghini C; Paoletti S; Uguccioni M; Gerber B
    J Leukoc Biol; 2004 Sep; 76(3):701-8. PubMed ID: 15178708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoreactivity to cell surface syndecans in cytoplasm and nucleus: tubulin-dependent rearrangements.
    Brockstedt U; Dobra K; Nurminen M; Hjerpe A
    Exp Cell Res; 2002 Apr; 274(2):235-45. PubMed ID: 11900484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding of HCV E2 to CD81 induces RANTES secretion and internalization of CC chemokine receptor 5.
    Nattermann J; Nischalke HD; Feldmann G; Ahlenstiel G; Sauerbruch T; Spengler U
    J Viral Hepat; 2004 Nov; 11(6):519-26. PubMed ID: 15500552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RANTES/CCL5-induced pro-angiogenic effects depend on CCR1, CCR5 and glycosaminoglycans.
    Suffee N; Hlawaty H; Meddahi-Pelle A; Maillard L; Louedec L; Haddad O; Martin L; Laguillier C; Richard B; Oudar O; Letourneur D; Charnaux N; Sutton A
    Angiogenesis; 2012 Dec; 15(4):727-44. PubMed ID: 22752444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple pathways of amino terminal processing produce two truncated variants of RANTES/CCL5.
    Lim JK; Burns JM; Lu W; DeVico AL
    J Leukoc Biol; 2005 Aug; 78(2):442-52. PubMed ID: 15923218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recognition of RANTES by extracellular parts of the CCR5 receptor.
    Duma L; Häussinger D; Rogowski M; Lusso P; Grzesiek S
    J Mol Biol; 2007 Jan; 365(4):1063-75. PubMed ID: 17101151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A model for non-viral gene delivery: through syndecan adhesion molecules and powered by actin.
    Kopatz I; Remy JS; Behr JP
    J Gene Med; 2004 Jul; 6(7):769-76. PubMed ID: 15241784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Syndecan-1 and syndecan-4 are involved in RANTES/CCL5-induced migration and invasion of human hepatoma cells.
    Charni F; Friand V; Haddad O; Hlawaty H; Martin L; Vassy R; Oudar O; Gattegno L; Charnaux N; Sutton A
    Biochim Biophys Acta; 2009 Oct; 1790(10):1314-26. PubMed ID: 19632304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spirodiketopiperazine-based CCR5 inhibitor which preserves CC-chemokine/CCR5 interactions and exerts potent activity against R5 human immunodeficiency virus type 1 in vitro.
    Maeda K; Nakata H; Koh Y; Miyakawa T; Ogata H; Takaoka Y; Shibayama S; Sagawa K; Fukushima D; Moravek J; Koyanagi Y; Mitsuya H
    J Virol; 2004 Aug; 78(16):8654-62. PubMed ID: 15280474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. pH-independent endocytic cycling of the chemokine receptor CCR5.
    Signoret N; Christophe T; Oppermann M; Marsh M
    Traffic; 2004 Jul; 5(7):529-43. PubMed ID: 15180829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Syndecan-4-dependent migration of human eosinophils.
    Feistritzer C; Kaneider NC; Sturn DH; Wiedermann CJ
    Clin Exp Allergy; 2004 May; 34(5):696-703. PubMed ID: 15144459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analyzing ligand and small molecule binding activity of solubilized GPCRs using biosensor technology.
    Navratilova I; Dioszegi M; Myszka DG
    Anal Biochem; 2006 Aug; 355(1):132-9. PubMed ID: 16762304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined blockade of the chemokine receptors CCR1 and CCR5 attenuates chronic rejection.
    Yun JJ; Whiting D; Fischbein MP; Banerji A; Irie Y; Stein D; Fishbein MC; Proudfoot AE; Laks H; Berliner JA; Ardehali A
    Circulation; 2004 Feb; 109(7):932-7. PubMed ID: 14757698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Large-scale expression and purification of the major HIV-1 coreceptor CCR5 and characterization of its interaction with RANTES.
    Nisius L; Rogowski M; Vangelista L; Grzesiek S
    Protein Expr Purif; 2008 Oct; 61(2):155-62. PubMed ID: 18588983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.